华蟾素对SD大鼠膀胱肿瘤的抑制作用  被引量:3

Therapeutic effect of cinobufagin on bladder tumor in SD rats:an in vivo experiment

在线阅读下载全文

作  者:李建昌[1] 柳建军[1] 凌生涛[1] 

机构地区:[1]广东医学院附属医院泌尿外科,广东湛江524000

出  处:《第三军医大学学报》2012年第8期726-728,共3页Journal of Third Military Medical University

基  金:广东医学院青年基金(2009-0854)~~

摘  要:目的研究华蟾素对SD大鼠膀胱肿瘤的治疗作用。方法 50只SD大鼠按随机分为对照组和实验组,实验组40只大鼠膀胱灌注N-甲基-N-亚硝基脲(N-methyl-N-nitrosourea,MUN),每3周1次,共4次;于第14周将实验组大鼠随机分为生理盐水组(膀胱灌注生理盐水)、丝裂霉素组(5 mg/kg)、低浓度华蟾素组(5 mg/kg)及高浓度华蟾素组(20 mg/kg),每周灌注1次,连续灌注5次,计算抑瘤率,TUNEL法检测肿瘤细胞的凋亡情况。结果 MNU膀胱灌注成功建立膀胱肿瘤动物模型,以膀胱肿瘤质量计算高浓度华蟾素组的抑瘤率为76.7%,高浓度华蟾素组抑瘤率较丝裂霉素组及低浓度华蟾素组高;TUNEL法检测高浓度华蟾素组AI值为(24.21±1.24)%,较其他各组AI值明显增高,提示高浓度华蟾素组凋亡指数高于丝裂霉素及低浓度华蟾素组。结论华蟾素对膀胱肿瘤有抑制生长、促进凋亡的作用,且高浓度时抑瘤作用及促凋亡作用较强。Objective To study the therapeutic effect of cinobufagin on bladder cancer. Methods Fifty SD rats were randomly divided into experimental group (n = 40) and control group (n = 10). N-methyl-N- nitrosourea (N-MNU) was infused into bladder of rats in experimental group (2.5 mg every 3 weeks, for 4 times), and after that, the rats of later group were divided into saline group, mitomycin group (5 mg/kg), low dose cinobufagin group (5 mg/kg) and high dose cinobufagin group (20 mg/kg), into which saline, mitomycin, low and and high dose cinobufagin were infused, once a week, for 5 times. Tumorinhibiting rate of cinobufacin was calculated and apoptosis of tumor cells was detected by TUNEL assay. Results The animal bladder tumor model was successfully established by infusing N-MNU into bladder. The tumor-inhibiting rate was 76.7% and the apoptosis index (AI) was (24.21 + 1.24)% in high dose cinobufotalin group, which were significantly higher than those in low dose cinobufotalin group and mitomycin group ( P 〈 0. 05). Conclusion Cinobufagin can inhibit the growth of bladder tumor in SD rats, and promote apoptosis of bladder tumor cells. The higher the cinobufotalin level is, the stronger the apoptosis-promoting effect of cinobufotalin is.

关 键 词:MNU 动物模型 膀胱肿瘤 SD大鼠 华蟾素 

分 类 号:R282.74[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象